Aligos Therapeutics Inc
(ALGS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,068 | 81,462 | 86,520 | 71,193 | 106,121 |
| Marketable Securities | 24,845 | 44,480 | 55,864 | 88,172 | 78,660 |
| Other current assets | 5,516 | 7,603 | 7,709 | 8,320 | 10,295 |
| TOTAL | $109,429 | $133,545 | $150,093 | $167,685 | $195,076 |
| Non-Current Assets | |||||
| PPE Net | 4,369 | 4,816 | 5,250 | 5,781 | 6,018 |
| Other Non-Current Assets | 7,940 | 8,332 | 8,726 | 9,057 | 9,376 |
| TOTAL | $12,309 | $13,148 | $13,976 | $14,838 | $15,394 |
| Total Assets | $121,738 | $146,693 | $164,069 | $182,523 | $210,470 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,822 | 4,737 | 2,931 | 2,762 | 3,755 |
| Accrued Expenses | 15,081 | 16,039 | 13,678 | 12,824 | 19,239 |
| TOTAL | $28,079 | $33,129 | $30,541 | $31,653 | $41,356 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,027 | 9,210 | 10,725 | 13,133 | 15,067 |
| Other Non-Current Liabilities | 8,611 | 9,201 | 9,785 | 10,435 | 10,985 |
| TOTAL | $8,909 | $9,664 | $11,515 | $13,889 | $16,228 |
| Total Liabilities | $36,988 | $42,793 | $42,056 | $45,542 | $57,584 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,718 | 1,718 | 1,713 | 1,712 | 1,708 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -422,073 | -399,118 | -377,232 | -358,611 | -338,687 |
| Other shareholders' equity | 499 | 401 | 159 | 50 | 204 |
| TOTAL | $84,750 | $103,900 | $122,013 | $136,981 | $152,886 |
| Total Liabilities And Equity | $121,738 | $146,693 | $164,069 | $182,523 | $210,470 |